Market

Income Statement

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

Fredun Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 344.19 P/BV 2.63 Book Value ( ₹ ) 277.17
52 Week High/Low ( ₹ ) 956/635 FV/ML 10/1 P/E(X) 16.54
Book Closure 30/09/2024 EPS ( ₹ ) 44.07 Div Yield (%) 0.10
(₹ in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]451.71346.58274.34221.74131.48
Other Operating Revenues0.001.580.332.722.41
Total Operating Revenues451.71348.16274.68224.46133.89
      
Other Income4.560.921.821.631.40
Total Revenue456.27349.07276.50226.09135.29
      
EXPENSES     
Cost Of Materials Consumed323.98283.76246.40177.11101.08
Operating And Direct Expenses0.0013.629.587.154.77
Changes In Inventories Of FG,WIP And Stock-In Trade6.05-22.44-37.72-0.011.17
Employee Benefit Expenses22.2312.5011.5310.668.66
Finance Costs22.3813.659.284.674.16
Depreciation And Amortisation Expenses4.453.802.812.162.00
Other Expenses48.9122.7317.1015.759.08
Total Expenses428.00327.62258.99217.49130.92
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax28.2721.4517.518.604.37
      
Exceptional Items0.000.000.000.00-1.16
Profit/Loss Before Tax28.2721.4517.518.603.21
      
Tax Expenses-Continued Operations     
Current Tax7.465.544.292.210.76
Deferred Tax0.000.292.410.050.44
Total Tax Expenses7.465.836.702.261.19
Profit/Loss After Tax And Before ExtraOrdinary Items20.8115.6210.816.342.01
      
Profit/Loss From Continuing Operations20.8115.6210.816.342.01
      
Profit/Loss For The Period20.8115.6210.816.342.01
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)44.8333.6624.1311.285.05
Diluted EPS (Rs.)44.8333.3222.9311.285.05
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend0.000.330.310.310.27
Equity Dividend Rate (%)7.007.007.007.007.00